Status:
COMPLETED
Chromoendoscopy for Serrated Polyposis Syndrome
Lead Sponsor:
Hospital Universitario de Móstoles
Conditions:
Colonic Polyp
Colonic Neoplasms
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Serrated polyposis syndrome (SPS) is the most common colorectal polyposis syndrome and is characterized by the combination of large and/or numerous serrated lesions (SLs) throughout the colorectum. SL...
Detailed Description
Serrated polyposis syndrome (SPS) is the most common colorectal polyposis syndrome and is characterized by the combination of large and/or numerous serrated lesions (SLs) throughout the colorectum. SL...
Eligibility Criteria
Inclusion
- Patients with Serrated Polyposis Syndrome aged 18 years or older, fulfilling WHO criteria I or III.
- Clearing of all polyps previously achieved. Polyp "clearing" considered when all polyps \>3 mm were removed during previous colonoscopies and/or partial colonic surgery when needed.
- Surveillance colonoscopy.
Exclusion
- Inflammatory bowel disease.
- Hereditary CRC syndromes (i.e, APC, MUTYH - biallelic - and MMR genes germline mutations).
- Total colectomy.
- Decline for participation.
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03476434
Start Date
February 1 2015
End Date
July 1 2016
Last Update
March 27 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.